Navigation Links
Usage Of Oral Contraceptives Need Not Be Feared By SLE Patients

In a research co headed by Jill Buyon, M.D., of New York’s Hospital for Joint Diseases said that oral contraceptives can be given to women with inactive or stable Systemic// Lupus Erythematosus (SLE) and they would not show symptoms of increased risk of flares of the disease.

This research was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health (NIH). In this disease the body fails to recognize as self and starts to attack its own tissues of the skin, joints and other internal organs.

Initially clinicians are very hesitant to give contraceptive pills (orally) to the patients with SLE because of the fear that they might show increased and unwanted disease activity.

This study which included 183 women with inactive or stable SLE were given oral contraceptives (triphasic 35 μg.ethinylestradiol/0.5-1 mg norethindrone for twelve 28-day cycles).they did not show any difference in reaction when compared to the controls who were given placebo.

Seven percent of the women showed severe reaction in both the test as well as in control categories. They suffered from various symptoms like new or worsening central nervous system involvement; inflammation of the blood vessels (vasculitis), kidneys (nephritis) and/or muscles (myositis); and/or blood problems, low platelet count (thrombocytopenia) and complete destruction of the red blood cells (hemolytic anemia).

Moderate reactions were seen in both the categories over the one year follow up session which includes fevers, inflammation of the skin, joints, pericarditis, and mucous membranes lining the nose and mouth.

This disease is very common among women. The ratio of women to men suffering from this disease is 10:1. Women usually suffer during the child bearing age when the female hormones are at its peak.

When experiments were conducted with mouse with SLE they showed increased reaction when administered with estrogen. They also affected the B cells which plays a vital role in the disease process.

According to this study it is clearly seen that women suffering with inactive or stable SLE can take estrogen without any fear of increased reaction due to the disease. But on the other hand women suffering from a risk of blood clots are not supposed to take oral contraceptives as estrogen increases blood clot formation.

Hence in conclusion this study has improved the quality of the life of people with rheumatic disease
'"/>




Related medicine news :

1. Usage of coil better in brain haemorrhage
2. Oxygen Usage During Exercise Could Indicate Heart Problems
3. The Usage Of Anti-Inflammatory Drugs Questioned
4. Drug Pramipexole Usage Linked To Gambling Addiction In Parkinsons Patients
5. Generic Drugs Usage In US Can Save $20 Billion – Express Script Surve
6. Safety Of Indian Sex Workers At Risk Due To Poor Condom Usage
7. Dummy Usage Raises Doubts.
8. More The Usage More The Growth In The Adult Brain.
9. Ignorance in the Usage of Pill Persists Among Many Women
10. Vaticans Council Reviews Condom Usage
11. Large Scale Free Access On Usage Of HIV Drugs Could Help In Fighting Its Spread
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... , ... February 24, 2017 , ... ... into the Senior International Elite division on February 12th. Ms. Esparza qualified ... at the elite qualifier competition held in Las Vegas, Nevada. Frida is one ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an official 2017 partnership with The Jensie Gran Fondo of Marin. For the ... UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide ...
(Date:2/23/2017)... ... February 23, 2017 , ... The 89th Academy Awards will be celebrated this ... Education Policy Center Bunkum Award. We invite you to enjoy our 11th annual tongue-in-cheek ... winner is the Center for American Progress (CAP), for its report, Lessons From State ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... clinician-based audience, will be participating in Rare Disease Day events, hosted by the ... addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will be ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, ... June: From Not to Hot,” which will begin airing on February 24, 2017. The ... millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb 23, 2017 Research and ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... drug pricing data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer ...
(Date:2/23/2017)... Regulus Therapeutics Inc . (Nasdaq: RGLS), ... innovative medicines targeting microRNAs, today announced it will release ... Thursday, March 2, 2017 after the market closes. ... on March 2, 2017 at 5:00 p.m. Eastern Time ... results and provide a general business update.  A live ...
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... & Trends - Industry Forecast to 2025" report to their ... The ... around 6.9% over the next decade to reach approximately $47.6 billion ... estimates and forecasts for all the given segments on global as ...
Breaking Medicine Technology: